High Density SNP Array Analysis of Tyrosine Kinase Inhibitor (TKI) Resistant Chronic Myeloid Leukemia (CML) Shows Secondary Genomic Alterations

被引：0

作者：

Nowak, Daniel ^{[1
]}

Kawamata, Norihiko ^{[1
]}

Akagi, Tadayuki ^{[1
]}

Okamoto, Ryoko ^{[1
]}

Thoennissen, Nils ^{[1
]}

Hofmann, Wolf-Karsten ^{[2
]}

Kato, Motohiro ^{[3
]}

Haferlach, Torsten ^{[4
]}

Ogawa, Seishi ^{[3
]}

Koeffler, H. Phillip ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Div Hematol & Oncol, Los Angeles, CA USA

[2] Charite, Dept Hematol & Oncol, Berlin, Germany

[3] Univ Tokyo, Tokyo, Japan

[4] MLL Munchner Leukamie Labor GmbH, Munich, Germany

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1091 / 1092

页数：2

共 50 条

[31] Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells [J].

Halbach, Sebastian ;

Hu, Zehan ;

Gretzmeier, Christine ;

Ellermann, Julia ;

Woehrle, Franziska U. ;

Dengjel, Joern ;

Brummer, Tilman .

CELL COMMUNICATION AND SIGNALING, 2016, 14

[32] The Role of Hypoxia on ABL Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia Cells [J].

Okabe, Seiichi ;

Tanaka, Yuko ;

Moriyama, Mitsuru ;

Gotoh, Akihiko .

BLOOD, 2019, 134

[33] Clarithromycin potentiates tyrosine kinase inhibitor treatment in patients with resistant chronic myeloid leukemia [J].

Carella, Angelo Michele ;

Beltrami, Germana ;

Pica, Gianmatteo ;

Carella, Andrea ;

Catania, Gioacchino .

LEUKEMIA & LYMPHOMA, 2012, 53 (07) :1409-1411

[34] Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells [J].

Sebastian Halbach ;

Zehan Hu ;

Christine Gretzmeier ;

Julia Ellermann ;

Franziska U. Wöhrle ;

Jörn Dengjel ;

Tilman Brummer .

Cell Communication and Signaling, 14

[35] INCREASING BURDEN OF TYROSINE KINASE INHIBITOR (TKI) TREATMENT FAILURE WITH LATER LINES OF THERAPY (LOT) IN CHRONIC MYELOID LEUKEMIA (CML): A REAL WORLD RETROSPECTIVE DATABASE ANALYSIS [J].

Chen, Y. J. ;

Huang, H. ;

Divino, V ;

Pokras, S. M. ;

Hallinan, S. ;

Munakata, J. ;

Taylor, C. ;

McGarry, L. ;

Ng, D. ;

Nieset, C. ;

Malone, D. .

VALUE IN HEALTH, 2014, 17 (03) :A78-A79

[36] Aplastic anemia secondary to tyrosine kinase inhibitor therapy in a patient with chronic myeloid leukemia [J].

Kassar, Olfa ;

Mallek, Rahma ;

Ben Said, Fatma ;

Kallel, Faten ;

Ksouda, Kamilia ;

Khabir, Abdelmajid ;

Elloumi, Moez .

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) :504-507

[37] Management of Chronic Myeloid Leukemia (CML) during Pregnancy Among Patients (pts) Treated with a Tyrosine Kinase Inhibitor (TKI): A Single-Center Experience [J].

Assi, Rita ;

Kantarjian, Hagop M. ;

Keating, Michael J. ;

Pemmaraju, Naveen ;

Verstovsek, Srdan ;

Garcia-Manero, Guillermo ;

Ravandi, Farhad ;

Borthakur, Gautam ;

Dahl, Jenny ;

Jabbour, Elias J. ;

Cortes, Jorge E. .

BLOOD, 2017, 130

[38] Impact of Tyrosine Kinase Inhibitor (TKI) in Chronic Myeloid Leukemia (CML) Relapsing After T Cell Depleted Allogeneic Stem Cell Transplantation (SCT) [J].

Ito, Sawa ;

Battiwalla, Minoo ;

Koklanaris, Eleftheria K. ;

Superata, Jeanine ;

Childs, Richard ;

Barrett, John .

BLOOD, 2011, 118 (21) :1188-1189

[39] Optimal Timing of Allogeneic Stem Cell Transplantation (Allo-SCT) for Chronic Myeloid Leukemia (CML) Patients in the Tyrosine Kinase Inhibitor (TKI) Era [J].

Hu, Bei ;

Lin, Xiao ;

Lee, Hans C. ;

Huang, Xuelin ;

Slack, Rebecca ;

Jabbour, Elias J. ;

Verstovsek, Srdan ;

Ravandi, Farhad ;

Garcia-Manero, Guillermo ;

Champlin, Richard E. ;

Hu, Zhen-Huan ;

Ahn, Kwang Woo ;

Lee, Ying ;

Popat, Uday ;

Sobecks, Ronald ;

Alyea, Edwin ;

Kantarjian, Hagop M. ;

Cortes, Jorge E. ;

Saber, Wael .

BLOOD, 2017, 130

[40] Discontinuation of Tyrosine Kinase Inhibitor (TKI) Therapy in Select Chronic Myeloid Leukemia (CML) Patients Within Veterans Integrated Services Network (VISN) 21 [J].

Werner, Kirsten ;

Carmichael, Jenna ;

Taylor, Janice ;

Flynn, Steve ;

Huberman, David .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025, 82 :S152-S152

← 1 2 3 4 5 →